Golden cross of Inovio Pharmaceuticals

18 янв. 2021 г.

INO’s long-term diagram shows that the stock’s 30 months SMA of prices crossovers the 200 months SMA.

This event marks the change of the 20-year downward trend to an upward one. This is a powerful long-term GOLDEN CROSS that will likely bring big profits in the future,
taking under consideration that INO has a very worthy vaccine for covid-19 in the 2-3 phase of testing, has very important funders and a very promising pipeline.

Below are presented the diagrams of mid and short term trend of the stock. Notice that in the 30 minutes diagram show up a short-term golden cross too.

21 янв. 2021 г.

Заметка

Disclaimer
The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.